In the present study, we recruited 590 glioma patients from CGGA RNA-seq (training set), and GSE 16011 array (validation set) sets to compare the mRNA expression level of DZIP3 from different clinical and molecular glioma subtypes. The gene discussed is DZIP3; the disease is central nervous system cancer.